Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-34.86	9.42	14.45
Graham Fair Price	139.52	12295.34	5133.36
PEG	-96.65	< 0.005	-0.25
Price/Book	11.74	0.36	0.33
Price/Cash Flow	7.83	15.63	14.49
Prices/Earnings	-80.64	4.12	21.27
Price/Sales	17.70	1.35	1.15
Price/FCF	7.83	15.63	14.49
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.62	0.18	0.18
Operating Margin	20.12	0.07	0.05
ROA	472.49	0.01	< 0.005
ROE	< 0.005	0.02	477.20
ROIC	< 0.005	0.01	409.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.01	50.18
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.34	0.14	-60.07
EPS QOQ	-0.85	4.89	477.80
FCF QOQ	-0.45	0.03	-92.70
Revenue QOQ	0.04	-0.05	41.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	27.97	28.11	0.50
Days Sales Outstanding (DSO)	56.53	57.82	2.27
Inventory Turnover	3.22	3.20	-0.49
Debt/Capitalization	0.11	0.11	0.17
Quick Ratio	2.20	2.21	0.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17480.01	17426.80	-0.30
Cash	5024.09	5163.43	2.77
Capex	-143.32	-174.34	-21.64
Free Cash Flow	393.31	406.35	3.31
Revenue	4957.90	4692.86	-5.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.68	2.70	0.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.30	1.92	-41.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating